(Photo Courtesy: www.thecapitalgrille.com)
After being named as one of America's best employers by Forbes, Quintiles, for the third time in the last four years has been named the best clinical research organization (CRO) at the Vaccine Industry Excellence (ViE) Awards.
Presented at the World Vaccine Congress in Washington DC, the awards recognize the efforts and achievements of companies and individuals in the vaccine industry during the previous year.
"We are honored to once again receive this prestigious award reflecting the insight of many from across the biopharmaceutical industry," said Mr Phil Breitfeld, vice president & head, Therapeutic Centers of Excellence, Quintiles. "It is clear to us all that the healthcare industry has a tremendous opportunity to conquer the global burden of disease. We're proud to be working alongside our customers to develop and commercialize vaccines and anti-infective products that contribute to those efforts and can help create a healthier world."
The award winner is selected by leaders from biopharmaceutical companies and other industry experts who vote online for their preferred provider prior to the World Vaccine Congress.
